Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
130 hedge funds and large institutions have $781M invested in Amicus Therapeutics in 2016 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 57 increasing their positions, 29 reducing their positions, and 22 closing their positions.
132% more call options, than puts
Call options by funds: $8.39M | Put options by funds: $3.62M
97% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 29
2% more funds holding
Funds holding: 128 → 130 (+2)
9% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 22
10.32% less ownership
Funds ownership: 109.97% → 99.65% (-10%)
34% less capital invested
Capital invested by funds: $1.18B → $781M (-$398M)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$28.7M |
| 2 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
+$9.72M |
| 3 |
AG
Artal Group
Luxembourg
|
+$8.74M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.93M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$31M |
| 2 |
MMPI
Morgenthaler Management Partners IX
Portola Valley,
California
|
-$15.1M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$9.36M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$9.29M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$6.63M |
FOLD Hedge Fund Activity: Q2 2016 in Review
130 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q2 2016, worth a combined $781M — down 34% from $1.18B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new FOLD positions and 22 closed out — a net gain of 2 holders — while 57 added to existing stakes and 29 trimmed.
The largest buyer was Pictet Asset Management (UK), adding an estimated $28.7M. The largest seller was Sectoral Asset Management, cutting an estimated $31M.
- 130 institutional investors held Amicus Therapeutics (FOLD) as of Q2 2016, up from 128 in Q1 2016.
- Funds reported $781M of Amicus Therapeutics stock for Q2 2016, down 34% quarter-over-quarter.
- 24 funds opened new Amicus Therapeutics positions in Q2 2016 and 22 closed out, a net change of +2 holders.
- The largest Amicus Therapeutics buyer in Q2 2016 was Pictet Asset Management (UK), an estimated $28.7M added.
- The largest Amicus Therapeutics seller in Q2 2016 was Sectoral Asset Management, an estimated $31M sold.
Based on aggregated 13F filings for Q2 2016.